Results 21 to 30 of about 8,939 (157)

Junctional Bradycardia as Early Sign of Digoxin Toxicity in a Premature Infant with Congestive Heart Failure due to a Left to Right Shunt

open access: yesAmerican Journal of Perinatology Reports, 2016
Introduction Congestive heart failure due to left to right cardiac shunt is usually managed medically with diuretics, angiotensin converting enzyme inhibitors, and, in some cases, with the addition of digoxin.
Soham Dasgupta   +2 more
doaj   +1 more source

Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits

open access: yesPharmacology Research & Perspectives, 2021
To evaluate the ocular safety of intravitreal carboplatin and digoxin injections as a new intravitreal chemotherapy option for retinoblastoma tumor vitreous seeds. Eighteen rabbits were divided randomly into three groups to receive intravitreal injection
Alireza Khodabande   +6 more
doaj   +1 more source

12-TOXICOPATHOLOGICAL AND BIOCHEMICAL STUDY OF MULTIPLE DOSES DIGOXIN IN SPRAGUE DAWLEY RATS [PDF]

open access: yesBasrah Journal of Veterinary Research, 2018
The current study was conducted at the college of veterinary medicine, university of basrah in the periods extended from 22/10/2016 to 22/1/2017.
Saleh K. Majeed, Abbas A. Khadhair
doaj   +1 more source

Digoxin Toxicity [PDF]

open access: yesArchives of Internal Medicine, 1998
Serum digoxin concentrations (SDCs) are frequently sampled before completion of drug distribution. If elevated, these concentrations may be misinterpreted, potentially leading to a misdiagnosis of digoxin toxicity.To determine the frequency of elevated SDCs (>2.6 nmol/L [>2.0 ng/mL]) obtained at appropriate postdosing intervals and to evaluate the ...
K M, Williamson   +7 more
openaire   +2 more sources

Digoxin Therapy of Fetal Superior Ventricular Tachycardia: Are Digoxin Serum Levels Reliable?

open access: yesAmerican Journal of Perinatology Reports, 2016
Background Despite its seldom occurrence, fetal tachycardia can lead to poor fetal outcomes including hydrops and fetal death. Management can be challenging and result in maternal adverse effects secondary to high serum drug levels required to achieve ...
Antonio F. Saad   +2 more
doaj   +1 more source

Digoxin toxicity presenting as encephalopathy [PDF]

open access: yesPostgraduate Medical Journal, 1996
Summary We describe two cases of digoxin toxicity presenting with clinical and electroencephalographic evidence of encephalopathy without other features of digoxin toxicity.
J R, Greenaway   +2 more
openaire   +2 more sources

A Fatal Case of Suicide Fruit Ingestion in Singapore by Cerbera Cardiac Glycoside Intoxication: Case Report and Review of Literature [PDF]

open access: yesAsia Pacific Journal of Medical Toxicology, 2020
Case Presentation: We present a case of Cerbera fruit ingestion which highlight the knowledge gap in unusual glycoside poisoning. Despite the patient’s asymptomatic presentation, life threatening clinical features such as hyperkalaemia, hypotension and ...
Yee Shay Lee   +3 more
doaj   +1 more source

What Is the Optimal Digoxin Level? Challenging Case of Fetal Atrial Flutter Treatment in a Monochorionic Diamniotic Twin

open access: yesMedicina, 2023
Background: Atrial flutter is an infrequent yet potentially fatal arrhythmia. Digoxin is the preferred first-line treatment for fetal atrial flutter due to its efficacy and favorable safety profile.
Soo Jung Kim   +5 more
doaj   +1 more source

Retrospective evaluation of patients with elevated digoxin levels at an emergency department

open access: yesTurkish Journal of Emergency Medicine, 2016
Objectives: We investigated the demographic characteristics, clinical and laboratory findings, treatment strategies and clinical outcomes of patients presenting at emergency department (ED) with digoxin levels at or above 1.2 ng/ml. Materials and methods:
Gulsum Limon   +4 more
doaj   +1 more source

Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin

open access: yesPharmaceutics, 2021
Digoxin is a hydrophobic drug used for the treatment of heart failure that possesses a narrow therapeutic index, which raises safety concerns for toxicity. This is of utmost relevance in specific populations, such as the elderly.
Daniela A. Rodrigues   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy